Phytochemical screening and evaluation of cardioprotective activity of ethanolic extract of  (basil) against isoproterenol induced myocardial infarction in rats by unknown
Fathiazad et al. DARU Journal of Pharmaceutical Sciences 2012, 20:87
http://www.darujps.com/content/20/1/87RESEARCH ARTICLE Open AccessPhytochemical screening and evaluation of
cardioprotective activity of ethanolic extract of
Ocimum basilicum L. (basil) against isoproterenol
induced myocardial infarction in rats
Fatemeh Fathiazad1, Amin Matlobi2, Arash Khorrami3, Sanaz Hamedeyazdan1, Hamid Soraya3, Mojtaba Hammami3,
Nasrin Maleki-Dizaji3 and Alireza Garjani3*Abstract
Background and the purpose of the study: The objectives of the present study were phytochemical screening
and study of the effects of ethanolic extract of aerial parts of Ocimum basilicum (basil) on cardiac functions and
histopathological changes in isoproterenol-induced myocardial infarction (MI).
Methods: The leaves of the plant were extracted with ethanol by maceration and subjected to colorimetry to
determine flavonoids and phenolic compounds. High-performance TLC analysis and subsequent CAMAG's TLC
scanning were performed to quantify rosmarinic acid content. Wistar rats were assigned to 6 groups of normal
control, sham, isoproterenol, and treatment with 10, 20, and 40 mg/kg of the extract two times per day concurrent
with MI induction. A subcutaneous injection of isoproterenol (100 mg/kg/day) for 2 consecutive days was used to
induce MI.
Results: Phytochemical screening indicated the presence of phenolic compounds (5.36%) and flavonoids (1.86%).
Rosmarinic acid was the principal phenolic compound with a 15.74% existence. The ST-segment elevation induced
by isoproterenol was significantly suppressed by all doses of the extract. A severe myocardial necrosis and fibrosis
with a sharp reduction in left ventricular contractility and a marked increase in left ventricular end-diastolic pressure
were seen in the isoproterenol group, all of which were significantly improved by the extract treatment. In addition
to in-vitro antioxidant activity, the extract significantly suppressed the elevation of malondialdehyde levels both in
the serum and the myocardium.
Conclusion: The results of the study demonstrate that Ocimum basilicum strongly protected the myocardium
against isoproterenol-induced infarction and suggest that the cardioprotective effects could be related to
antioxidative activities.
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Ocimum basilicum (basil) is a plant from genus Ocimum
belonged to family Lamiaceae. Essential oil of the plant
is composed of interesting terpenoids and phenylpropa-
noids such as eugenol, methyl eugenol, citral, and me-
thyl chavicol [1]. In Iran the plant is called "rayhan" and
is being broadly used as vegetable and culinary herb and
also used in folk medicine to treat various diseases
including cardiovascular disorders. The leaves of O. basi-
licum are traditionally used as antispasmodic, carmina-
tive, digestive, stomachic, and tonic [2,3]. The merit of
the traditional use of O. basilicum has been supported
by some former studies from the genus Ocimum, provid-
ing several biologically active constituents present in the
extracts and essential oils of the plants. Since, the com-
plexity and chemical diversity of the compounds present
in medicinal herbs play an important role in the discov-
ery and development of new compounds, detecting the
naturally occurring constituents in plants seems to be of
value to achieve a better understanding of the relation
between chemical constituents and biological properties
of a medicinal plant. Concerning the prior phytochem-
ical reports from O. basilicum, it mainly produces triter-
penoids, polyphenols, steroids, and phenylpropanoids
some of which, such as basilol, ocimol, basilimoside, ros-
marinic acid, hydroxycinnamic acids, oleanolic acid, and
betulinic acid, have been proved for having prominent
biological properties [4,5]. Moreover, the essential oil
content may vary considerably among the species of Oci-
mum according to the plants growth stage, extraction
method, and climatic parameters as well as agrotechnical
factors. In the same way as Vani et al. had confirmed sig-
nificant differences in the proportions of volatile com-
pounds from O. basilicum and O. sanctum in relation to
the many factors that contribute to the fragrances con-
tent representing O. basilicum essential oil rich in me-
thyl chavicol and the essential oil from O. sanctum rich
in methyl eugenol [6].
Recently a considerable antihypertensive effect of O.
basilicum extract in renovascular hypertensive rats has
been reported [7]. The authors claimed that the effects
of O. basilicum extract on blood pressure, cardiac hyper-
trophy, and endothelin level are consistent with an effect
on endothelin-converting enzyme, and warrant further
exploration. A finding has also indicated that aqueous
and organic extracts of O. basilicum lower plasma lipid
levels and thereby the extracts might be beneficial in the
treatment of hyperlipidemia and atherosclerosis [8]. In
addition, a study by Sharma et al. (2001) demonstrated
that pre- and co-treatment with Ocimum sanctum, another
species from the genus of Ocimum, exhibited significant
protection against isoproterenol induced histopathological
and biochemical changes [9]. The cadioprotective mechan-
ism(s) appeared to be through modulation of variousantioxidant parameters thereby improving the overall anti-
oxidant defense of the myocardial tissue. In fact, the water
and ethanol extracts of O. basilicum have been shown to
have strong antioxidant activities [10].
Acute myocardial infarction is an important ischemic
heart disease and a leading cause of morbidity and mortal-
ity worldwide. Isoproterenol is a synthetic β-adernoceptor
agonist that its subcutaneous injection induces myocardial
infarction in rats [11] and results in irreversible cellular
damage and ultimately infarct-like necrosis [12,13]. The
acute phase of myocardial necrosis and dysfunction
induced by isoproterenol mimics changes in blood pres-
sure, heart rate, electrocardiogram (ECG), and left ven-
tricular dysfunction similar to that occurs in patients with
myocardial infarction. The rat model of isoproterenol-
induced myocardial infarction offers a reliable non-invasive
technique for studying the effects of various potential cardi-
oprotective agents [14]. Amongst various mechanisms pro-
posed to explain isoproterenol induced cardiac damage,
generation of highly cytotoxic free radicals through autoox-
idation of catecholamines has been implicated as one of the
important causative factor [15]. Although O. basilicum is
an important medicinal herb having antioxidant properties,
its cardioprotective activity against isoproterenol induced
myocardial infarction has not been studied. The aim of the
present study was to investigate the effect of oral adminis-
tration of hydroalcoholic extract of leaves of O. basilicum
on isoproterenol induced myocardial injury. Myocardial
dysfunction and histopathological changes induced by iso-
proterenol have been monitored and their modulation with
different doses of O. basilicum was evaluated.
Materials and methods
Plant material
The aerial parts of O. basilicum were purchased before
flowering in June from local market. The botanical iden-
tification was made by Dr. F. Fathiazad (Department of
Pharmacognosy). A voucher specimen was deposited at
the herbarium of the Faculty of Pharmacy, Tabriz Uni-
versity of Medical Sciences, Tabriz, Iran.
Extract preparation
The fresh leaves (500 g) were chopped up and extracted
with ethanol (96%; 2 L × 4) by maceration at room
temperature and the solvent was removed at 40°C using
a rotary evaporator. A greenish residue weighing 9.2 g
was obtained and kept in air tight bottle in a refrigerator
until use.
Determination of total phenolic compound
The total content of phenolic compounds was deter-
mined with the Folin-Ciocalteau reagent [16]. The ex-
tract samples (0.5 ml of different dilutions) were mixed
with Folin-Ciocalteu reagent (5 ml, 1:10 diluted with
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(1 M) were then added. The mixture was allowed to
stand for 15 min and the phenols were determined by
colorimetry at 765 nm. The standard curve was prepared
by 0, 50, 100, 150, 200, and 250 mg/ml solutions of gallic
acid in methanol:water (50:50, v/v). Total phenolic con-
tents were calculated as gallic acid equivalent per gram
of the extract from a calibration curve preaperd with 0,
50, 100, 150, 200, and 250 μg/ml solutions of gallic acid
in methanol.Determination of total flavonoid content
The content of flavonoids was determined using colori-
metric aluminum chloride method [16]. Briefly, 0.5 ml
solution of the extract were mixed with 1.5 ml of metha-
nol, 0.1 ml of 10% aluminum chloride, 0.1 ml of 1 M po-
tassium acetate and 2.8 ml of distilled water, and were
left at room temperature for 30 min. The absorbance of
the reaction mixture was measured spectrophotometric-
ally at 415 nm. Total flavonoids contents were calculated
as quercetin from a calibration curve.Quantitative analysis
A Preliminary HPTLC (high-performance TLC) analysis
of the extract was performed on silica gel 60 F254
HPTLC plate (Merck) with ethylacetate, methanol, and
water in the ratio of 100:13.5:10 as mobile phase and the
spots were detected under UV [17]. Subsequently, quan-
titative analysis of rosmarinic acid as the major compound
in the extract was performed using a fully automated
CAMAG’s TLC scanner 3 coupled with an automatic
TLC sampler 4, an automatic developing chamber 2, and
a TLC Visualizer (CAMAG; Switzerland). The winCATS
(Planar chromatography manager) software was used for
analyzing the results of the scan and image of the plate.Determination of in vitro total antioxidant activity
1,1-diphenyl-2-picryl-hydrazil (DPPH; Sigma-Aldrich
Quı0mica S.A., Madrid, Spain) was used to determine the
free radical-scavenging potential of the ethanolic extract.
IC50 (50% inhibitory concentrations) of the extract was
calculated versus MeOH as a negative control and rutin
was used as a positive control [18]. Briefly, a stock solu-
tion of the extract was prepared in MeOH to achieve the
concentration of 1 mg/ml. Dilutions were made to ob-
tain concentrations of 5 × 10-2, 5 × 10-3, 5 × 10-4, 5 × 10-5,
5 × 10-6 and 5 × 10-7 mg/ml. Two ml of each solution
was added to 2 ml of DPPH solution (in MeOH; 80 g/
ml). The absorbance was measured at 517 nm after
30 min of reaction at 25°C. The experiments were per-
formed in duplicate and the average absorption was
noted for each concentration.Animals
Male albino wistar rats (260-280 g) were used in this
study. Rats were housed at constant temperature (20 ±
1.8°C) and relative humidity (50 ± 10%) in standard poly-
propylene cages, six per cage, under a 12-h light/dark
cycle, and were allowed food and water freely. This study
was performed in accordance with the Guide for the
Care and Use of Laboratory Animals of Tabriz Univer-
sity of Medical Sciences, Tabriz-Iran (National Institutes
of Health publication No 85–23, revised 1985).
Induction of acute myocardial infarction
Isoproterenol (Sigma Co; USA) was dissolved in normal
saline and injected subcutaneously to rats (100 mg/kg)
for two consecutive days at an interval of 24 h to induce
acute myocardial infarction. Animals were sacrificed
48 h after the first dose of isoproterenol.
Experimental protocol
The animals were randomized into 6 groups consisting
of 6 rats each. Rats in group 1 (normal control) received
a subcutaneous injection of normal saline (0.5 ml) and
were left untreated for the whole period of the experi-
ment. In group 2 (sham) rats received a subcutaneous
injection of normal saline and O. basilicum extract was
given orally (40 mg/kg) two times per day for two days.
Rats in group 3 (isoproterenol group) received a sub-
cutaneous injection of isoproterenol (100 mg/kg) for two
consecutive days at an interval of 24 h and normal saline
as vehicle (0.5 ml) was given orally concurrent with and
8 h after each isoproterenol injection. Rats in groups 4
to 6 received a subcutaneous injection of isoproterenol
(100 mg/kg) for two consecutive days at an interval of
24 h, the extract was suspended in saline and given or-
ally (10, 20 and 40 mg/kg) concurrent with and 8 h after
each isoproterenol injection.
Hemodynamic measurements
Animals were anaesthetized by intraperitoneal injection
of ketamin, xylazin, and acepromazin mixture 48 h after
the first dose of isoproterenol. When the rats no longer
responded to external stimuli, the systemic arterial blood
pressure was recorded from a catheter inserted into the
left carotid artery. A standard limb lead II ECG was
monitored continuously throughout the experimental
period. The mean arterial blood pressure was calculated
from the systolic and diastolic blood pressure traces.
The heart rate was calculated from the ECG. To evaluate
the cardiac left ventricular function, a Mikro Tip cath-
eter transducer (Millar Instruments, INC) was advanced
into the lumen of the left ventricle. This helped to meas-
ure the left ventricular systolic pressure (LVSP), left ven-
tricular end-diastolic pressure (LVEDP), maximum and
minimum rates of developed left ventricular pressure
Figure 1 Photodensitogram of the fluorescent HPTLC plate of
rosmarinic acid (densitograms 1–8, from front to back,
affording 0.5, 1, 1.5, 2, 2.5, 3, 3.5, and 4 μg rosmarinic acid) and
O. basilicum ethanolic extract (densitograms from 9–14,
affording 20, 40, 60, and 80 μg of the extract) depicted by TLC
scanner 3(CAMAG) in which the X, Y and Z axis represents RF
of each detected spot, height of the peaks (Spot’s density), and
location on the plate, respectively.
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change at a fixed right ventricular pressure (LVdP/dt/P)
[19]. All the parameters were continuously recorded
using a Powerlab system (AD Instruments, Australia).
Tissue weights
After the hemodynamic measurements, the animals were
killed by an overdose of the anesthetic and the hearts were
removed and weighed. The wet tissue to body weight
ratios was calculated to assess the degree of congestion.
Histopathological examination
The hearts were fixed in 10% buffered formalin. The tis-
sues were embedded in paraffin, sectioned at 5 μm and
stained with hematoxylin and eosin (H&E) for evaluation
of histology, and Gomeri trichrome for distinguishing
muscle and interstitial connective tissue. Myocardial fi-
brosis and necrosis was evaluated in each section of the
heart tissue using a morphometric point-counting pro-
cedure [20]. Two persons graded the histopathological
changes as 1, 2, 3, and 4 for low, moderate, high, and in-
tensive pathological changes, respectively.
Determination of lipid peroxidation in serum and
myocardium
Malondialdehyde (MDA), a thiobarbiturate reactive sub-
stance, was measured as a marker for oxidative stress in
serum and myocardial homogenates using a method
prescribed by Satoh [21]. The lipid peroxide expressed
as nanomole MDA production per gram heart tissue
and nanomole per milliliter serum, were measured
spectrophotometrically.
Statistics
Data were presented as mean ± sem. One-way-ANOVA
was used to make comparisons between the groups. If
the ANOVA analysis indicated significant differences, a
Student–Newman–Keuls post test was performed to
compare the mean values between the treatment groups
and the control. Any differences between groups were
considered significant at P < 0.05.
Results
Phytochemical screening of O. basilicum extract
Preliminary phytochemical screening of hydroalco-
holic extract of O. basilicum indicated the presence
of flavonoids and phenolic compounds. The total
amount of phenolic compounds determined as gallic
acid was 53.66 mg/g extract (5.36%). The content of
flavonoids in the extract was 18.65 mg quercetin
equivalent/g of the extract (1.86%) by reference to a
standard curve: y = 0.008x-0.068; r2 = 0.999. HPTLC
analysis of the extract revealed the presence of ros-
marinic acid with Rf value of 0.31 as the majorcompound. In order to quantitative determination of
rosmarinic acid in the extract the fluorescent HPTLC
plate was placed on TLC scanner and scanned under
the UV 329 nm light. The resultant 3D graph was
depicted on the basis of optical density (densitogram)
(Figure 1). Further, the calibration curve was calcu-
lated automatically according to the densitogram data
and rosmarinic acid in the hydroalcoholic extract of
O. basilicum was calculated as 157.40 mg/g of O.
basilicum extract by reference to a standard curve: y =
0.0092x-3.6997; r2 = 0.9947.
In vitro antioxidant activity of O. basilicum extract
The ethanolic extract of O. basilicum was tested for its
free radical scavenging effect on DPPH. DPPH was
reduced concentration dependently by the extract. The
free radical scavenging potency of the extract (IC50) was
22.24 μg/ml. This value was 9.7 μg/ml for rutin as a
positive reference antioxidant.
Effects of O. basilicum extract on electrocardiogram
changes
The ECG from normal and treated rats has been shown in
Figure 2. The normal control group and the rats that had
received the extract alone (40 mg/kg; sham) showed nor-
mal patterns of ECG, whereas the rats treated with iso-
proterenol demonstrated a marked (p < 0.001) reduction
in the R-amplitude along with a significant (p < 0.001)
Normal Sham (OB40 mg/kg) Isoproterenol (Iso)



































Figure 2 Effect of the hydroalcoholic extract of O. basilicum (OB) on electrocardiographic patterns and changes (recorded from limb
lead II) in normal control, isoproterenol alone injected (MI), and treated rats. Values are mean ± sem (n = 6). aP < 0.001 from respective
control value; ***P < 0.001 as compared with isoproterenol treated group using one way ANOVA with Student-Newman-Keuls post hoc test.
Fathiazad et al. DARU Journal of Pharmaceutical Sciences 2012, 20:87 Page 5 of 10
http://www.darujps.com/content/20/1/87elevation of ST-segment, indicative of myocardial infarc-
tion (Figure 2). Treatment with all doses of the extract
exhibited a marked and dose dependent inhibition of the
elevation of ST-segment (p < 0.001). The extract also
increased the R-amplitude dose dependently, but this in-
crease did not attain a significant level (Figure 2).
Effects of O. basilicum extract on hemodynamic
responses
Isoproterenol injection (animals with myocardial in-
farction) caused a significant decrease in the mean
arterial blood pressure from 107 ± 6 mmHg in the
normal control to 66 ± 6 mmHg (p < 0.01; Table 1).
There was a considerable (p < 0.001) increase in the
mean arterial blood pressure to 113±4 mmHg after
treatment with 40 mg/kg of O. basilicum extract.
The intraventricular pressure was measured to deter-
mine the degree of left ventricular responses to the
isoproterenol injection. Isoproterenol significantly
reduced the left ventricular systolic pressure (LVSP)
from 125±7 mmHg in the normal control group to72±9 mmHg (p < 0.001). All doses of the extract
increased the LVSP and the increase with 20 and
40 mg/kg of the extract was prominent (p < 0.01;
p < 0.001). There was almost a 3 fold elevation in the
left ventricular end diastolic pressure (LVEDP) in the
isoproterenol treated rats, thereby indicating left ven-
tricular dysfunction. All three doses of the extract consid-
erably (p < 0.001) improved the left ventricular function by
lowering LVEDP from 21±1.8 mmHg in the rats with myo-
cardial infarction to 5.8±1.1, 9.0±3.4, and 6.6±1.5 mmHg,
respectively (Table 1). When compared with the normal
control, the rats with left ventricular dysfunction (iso-
proterenol group) demonstrated a fall in the values of the
left ventricular maximal and minimal rates of pressure
(LV dP/dtmax; LV dP/dtmin, p < 0.001; p < 0.05; Figure 3)
as well as a lower rate of pressure change at a fixed ven-
tricular pressure (LV dP/dt/P, p < 0.01; Table 1). The
same as the LVSP changes, the indices of myocardial
contractility also showed marked and dose-dependent
improvements (p < 0.05; p < 0.01; p < 0.001) by all doses
of the extract.
Table 1 Effects of the hydroalcoholic extract of O. basilicum on hemodynamic and left ventricular function in rats
treated with isoproterenol
Groups MAP (mmHg) Herat rate (bpm) LVSP (mmHg) LVEDP (mmHg) LV dP/dt/P (1/sec)
N = 6
Control 107±6 255±5 125±7 6.3±1.1 64±2.3
Sham 106±6 249±10 117±4 5.6±0.9 60±1.4
Isoproterenol (Iso) 66±6b 323±15a 72±9c 21±1.2c 38±9.1b
O. basilicum (10 mg/kg) + Iso 78±6 285±19 95±4 5.8±1.1*** 69±4.5**
O. basilicum (20 mg/kg) + Iso 90±11 294±21 109±10** 9.0±3.4*** 73±4.6***
O. basilicum (40 mg/kg) + Iso 113±4*** 312±16 127±3*** 6.6±1.5*** 95±2.8***
Data are expressed as mean ± sem. MAP Mean arterial pressure, LVSP left ventricular systolic pressure, LVEDP left ventricular end diastolic pressure. ap < 0.05; bp <
0.01; cp < 0.001 from respective control value; *p < 0.05, **p < 0.01; ***p < 0.001 as compared with isoproterenol treated group using one way ANOVA with
Student-Newman-Keuls post hoc test.
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body weight ratio
In order to assess the extent of heart weight gain devel-
oped by the injection of isoproterenol, the heart weight
to body weight ratio was determined (Table 2). The ratio
was significantly higher in the isoproterenol treated rats
(4.16 ± 0.05) compared with the normal control group
(2.56 ± 0.02; p < 0.001). Oral treatment with 20 and
40 mg/kg of the O. basilicum extract exhibited a sub-
stantial reduction (p < 0.01 and p < 0.001, respectively) in
the heart to body weight ratio (Table 2).Histopathological examination of the cardiac tissues
In the normal control group, myocardial fibers were
arranged regularly with clear striations. No apparent de-
generation or necrosis was observed (Figure 4). Histo-
logical sections of the isoproterenol treated hearts showed
widespread subendocardial necrosis, hypertrophia, and
abundant fibroblastic hyperplasia along with increased
edematous intramuscular space (Figure 4 and Figure 5).
All the three doses of O. basilicum extract significantly
prevented myocardial necrosis and fibrosis. The O. basili-
cum extract with doses of 10, 20, and 40 mg/kg reduced
the isopreterenol-induced necrosis and edematous dose
dependently by 33% (p < 0.05), 44% (p < 0.001), and 48%
(p < 0.001), respectively as shown in Figure 6. The cardio-
myocyte fibrosis was also reduced by 24%, 37% (p < 0.01),
and 53% (p < 0.001; Figure 6).Figure 3 Left ventricular maximal and minimal rates of
pressure increase (LV dP/dtmax; LV dP/dtmin) in the control
group and in the rats treated with isoproterenol alone (rats
with myocardial infarction), O. basilicum extract alone (sham),
and isoproterenol plus O. basilicum extract. Iso: isoproterenol;
OB: O. basilicum extract. Values are mean ± sem (n = 6). ap < 0.05;
bp < 0.001 from respective control value; *p < 0.05, **p < 0.01,
***p < 0.001 as compared with isoproterenol treated group using
one way ANOVA with Student-Newman-Keuls post hoc test.Effects of O. basilicum extract on lipid peroxidation
To determine the lipid peroxidation, MDA levels were
measured in serum and myocardial homogenates. Both
serum and heart MDA levels were considerably increased
(p < 0.001) in isoproterenol injected rats (MI group) in
comparison with normal control (Table 2). Treatment
with O. basilicum extract markedly diminished the serum
MDA levels by 43-68% and myocardial MDA levels by 41-
64% (p < 0.001; Table 2).Disscussion
Ocimum basilicum L., known as basil, is a culinary herb
that is used in Asian and Italian cuisine. O. basilicum
are being used traditionally for the treatment of gastro-
intestinal disorders [2,3], diabetes [22], headaches, car-
diovascular and neurodegenerative disorders [23], and
as anti-inflammatory [24]. An endothelium-dependant
vasorelaxant and anti-platelet aggregation activities of an
aqueous extract from O. basilicum have also been reported
[25]. In the present study, we investigated the therapeutic
efficacy of the hydroalcoholic extract of leaves of the plant
in rats with myocardial infarction. A subcutaneous injec-
tion of a high dose of isoproterenol resulted in electrocar-
diographic, hemodynamic, and structural changes in the
heart very similar to that occurs in patients with myocar-
dial infarction. Isoproterenol elevated the ST-segment in
the ECG (diagnostic of myocardial infarction) and treat-
ment with the hydroalcoholic extract of O. basilicum
Table 2 The effects of oral administration of hydroalcoholic extract of O. basilicum extracrt on Heart weight (HW) to
body weight (BW) ratios, and on serum and myocardial malondialdehyde (MDA) levels
Groups (n = 5-6) HW/BW ratio (g/kg) Serum MDA (nmol/ml) Myocardium MDA (nmol/mg)
Control 2.56 ± 0.02 5.4 ± 0.48 1.6 ± 0.13
Isoproterenol 4.14 ± 0.05a 13.7 ± 0.2a 3.9 ± 0.36a
O. basilicum (10 mg/kg) + Iso 4.06 ± 0.05 7.9 ± 1.7*** 2.3 ± 0.19***
O. basilicum (20 mg/kg) + Iso 3.70 ± 0.11** 7.1 ± 0.4*** 1.7 ± 0.03***
O. basilicum (40 mg/kg) + Iso 3.43 ± 0.025*** 4.4 ± 0.4*** 1.4 ± 0.01***
Data are expressed as mean ± sem (n = 5-6). ap < 0.001 from respective control value; *p < 0.05; **p < 0.01; ***p < 0.001 as compared with isoproterenol treated
group using one way ANOVA with Student-Newman-Keuls post hoc test.
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the ST-segment elevation. Isoproterenol injection signifi-
cantly decreased the arterial pressure indices, contractility
(LVdP/dtmax) and relaxation (LVdP/dtmin), and increased
the left ventricular end-diastolic pressure (LVEDP). O.
basilicum substantially recovered the arterial pressure andFigure 4 Photomicrographs of sections of rat cardiac apexes. Heart tis
intensive cardiomyocyte necrosis and increased edematous intramuscular s
improvement. Iso: isoproterenol; OB: O. basilicum extract. H&E (40 M).improved the left ventricular performance along with a
simultaneous reduction in the LVEDP.
Myocardial infarction is a leading cause of mortality
and morbidity worldwide. Left ventricular dysfunction
and heart failure are common following a myocardial in-
farction and various treatments are given to prevent thesue of a rat subcutaneously injected with isoproterenol alone shows
pace. Treatment with O. basilicum extract demonstrates a marked
Figure 5 Heart tissue of a rat treated with isoproterenol shows an intensive fibrosis (blue spots are shown by arrows) and
angiogenesis. Pretreatment with O. basilicum extract significantly prevented the fibrosis. Iso: isoproterenol; OB: O. basilicum extract. Gomeri's
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Figure 6 The effects of oral administration of hydroalcoholic
extract of O. basilicum extracrt on grading of histopathological
changes in rats’s cardiac apex tissues (scors 1, 2, 3, and 4 show
low, moderate, high and intensive pathological changes,
respectively). Data are expressed as mean ± sem (n = 5-6). ap <
0.001 from respective control value; *p < 0.05; **p < 0.01; ***p < 0.001
as compared with isoproterenol treated group using one way
ANOVA with Student-Newman-Keuls post hoc test.
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therapy has been considered increasingly in the treat-
ment of myocardial infarction. There are considerable
epidemiological evidences suggesting that consumption
of fruits and vegetables, particularly green leafy vegeta-
bles is associated with a lower risk for coronary heart
diseases [26,27]. The beneficial effects of vegetables and
fruits could be due to the presence of compounds with
antioxidant properties. The formation of reactive oxygen
species plays a key role in cardiac pathophysiology.
Therefore, by targeting oxidative stress the treatment of
myocardial infarction can be substantially improved. In
fact, the acute phase of myocardial necrosis induced by
isoproterenol has been linked to generation of highly
cytotoxic reactive oxygen [12]. Several studies have
reported that O. basilicum has strong antioxidant prop-
erties and individual phenolic acid composition strongly
influences the antioxidant capacity [28,29].
Our preliminary phytochemical finding in this study
revealed the presence of phenolic compounds and
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O. basilicum leaves. Ever since oxidative stress related
conditions like isoproterenol induced damages are gen-
erated via an imbalance between the production of oxi-
dants and occurrence of antioxidant defenses, searching
for flavonoids and other phenolic compounds in O. basi-
licum extract is of value for quantifying the putative role
of them as antioxidant agents, for confronting this oxi-
dative stress. Considering the findings of the study, rad-
ical scavenging activity of the extract was in line with
the high phenolic and flavonoid contents of O. basilicum
extract. Moreover, rosmarinic acid with 15.74% presence
was identified as a major phenolic derivative of the O.
basilicum extract in the present study. Rosmarinic acid
which is commonly found in species of the lamiaceae
such as culinary herbs has a number of interesting bio-
logical activities, e.g. antiviral, antibacterial, antiinflam-
matory and antioxidant [30]. The results of the present
study show a considerable in vitro (IC50 = 22.24 μg/ml
compared with rutin with IC50 = 9.7 μg/ml) and in vivo
antioxidant activity of O. basilicum extract, so that the
extract diminished the myocardial and serum lipid per-
oxidation by 41-68%. Besides, it has been suggested that
the observed scavenging activity of the extract could be
assigned to the hydrogen-donating capacity of the phen-
olic and flavonoid components, present in sizeable
amounts of O. basilicum extract, signifying the potential
role of them in preventing the isoproterenol induced
damages in this study. Accordingly, developing an effi-
cient herbal remedy is reliant to a superior notion of the
relation between chemical constituents and biological
properties of the plant material.
Eventually, we conclude that short term administration
of hydroalcoholic extract of O. basilicum L. (basil) leaves
potently protects the myocardium against isoproterenol
induced infarction and suggest that the cardioprotective
effect of the extract could be related to its antioxidant
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